A detailed history of Gordian Capital Singapore Pte LTD transactions in Repligen Corp stock. As of the latest transaction made, Gordian Capital Singapore Pte LTD holds 1,800 shares of RGEN stock, worth $271,314. This represents 0.14% of its overall portfolio holdings.

Number of Shares
1,800
Holding current value
$271,314
% of portfolio
0.14%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 18, 2025

BUY
$123.41 - $160.92 $222,138 - $289,656
1,800 New
1,800 $259,000
Q2 2024

Aug 30, 2024

BUY
$120.0 - $182.95 $100,800 - $153,678
840 New
840 $105,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.36B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Gordian Capital Singapore Pte LTD Portfolio

Follow Gordian Capital Singapore Pte LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gordian Capital Singapore Pte LTD, based on Form 13F filings with the SEC.

News

Stay updated on Gordian Capital Singapore Pte LTD with notifications on news.